Literature DB >> 6319014

EGF, PGF2 alpha and insulin induce the phosphorylation of identical S6 peptides in swiss mouse 3T3 cells: effect of cAMP on early sites of phosphorylation.

J Martin-Pérez, M Siegmann, G Thomas.   

Abstract

Epidermal growth factor (10(-9)M), prostaglandin (8.5 X 10(-7)M), F2 alpha, and insulin (10(-9)M), each of which only leads to a partial phosphorylation of 40S ribosomal protein S6, generate the same first eight phosphopeptides induced by 10% serum, suggesting all three activate a common regulatory pathway for the phosphorylation of S6. Added together, they induce almost maximal S6 phosphorylation and a phosphopeptide pattern nearly equivalent to that of serum. Unlike the agents above, 8-Br-cAMP or PGE1 has no significant effect on protein synthesis, but does induce a small increase in S6 phosphorylation. Surprisingly, the three peptides that become phosphorylated are identical with insulin-induced phosphopeptides 10b, 11, and 9, based on either comigration, limited acid hydrolysis, or V8 protease digestion. Incubation of 40S subunits with cAMP-dependent protein kinase induces the phosphorylation of these same three phosphopeptides. The in vitro and in vivo studies described here raise the possibility that cAMP could, in part, be responsible for mediating the phosphorylation of S6 during the mitogenic response.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319014     DOI: 10.1016/0092-8674(84)90222-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  17 in total

1.  Cyclic AMP-dependent protein kinase regulates sensitivity of cells to multiple drugs.

Authors:  I Abraham; R J Hunter; K E Sampson; S Smith; M M Gottesman; J K Mayo
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

2.  Identical Mr 70,000 S6 kinase is activated biphasically by epidermal growth factor: a phosphopeptide that characterizes the late phase.

Authors:  M Susa; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Polyomavirus middle T antigen induces ribosomal protein S6 phosphorylation through pp60c-src-dependent and -independent pathways.

Authors:  D A Talmage; J Blenis; T L Benjamin
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

4.  Identification and characterization of a mitogen-activated S6 kinase.

Authors:  P Jenö; L M Ballou; I Novak-Hofer; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

5.  Phosphorylation of the yeast equivalent of ribosomal protein S6 is not essential for growth.

Authors:  C Kruse; S P Johnson; J R Warner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

6.  Both insulin and epidermal growth factor stimulate lipogenesis and acetyl-CoA carboxylase activity in isolated adipocytes. Importance of homogenization procedure in avoiding artefacts in acetyl-CoA carboxylase assay.

Authors:  T A Haystead; D G Hardie
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

7.  Fibroblast growth factor treatment of Swiss 3T3 cells activates a subunit S6 kinase that phosphorylates a synthetic peptide substrate.

Authors:  S L Pelech; B B Olwin; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

8.  Phosphorylation of the Saccharomyces cerevisiae equivalent of ribosomal protein S6 has no detectable effect on growth.

Authors:  S P Johnson; J R Warner
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

9.  Sequence and expression of chicken and mouse rsk: homologs of Xenopus laevis ribosomal S6 kinase.

Authors:  D A Alcorta; C M Crews; L J Sweet; L Bankston; S W Jones; R L Erikson
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

10.  Identification of mitogen-responsive ribosomal protein S6 kinase pp90rsk, a homolog of Xenopus S6 kinase II, in chicken embryo fibroblasts.

Authors:  L J Sweet; D A Alcorta; S W Jones; E Erikson; R L Erikson
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.